Desh Rakshak

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE971E01016
NSEID:
BSEID: 531521

INR

35.20

0.00 (0.00%)

BSENSE

Dec 05

BSE+NSE Vol: 1.2 k

{
  "main_header": {
    "sid": 351394,
    "name": "Desh Rakshak",
    "stock_name": "Desh Rakshak",
    "full_name": "Desh Rakshak Aushdhalaya Ltd",
    "name_url": "stocks-analysis/desh-rakshak",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "35.20",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "35.20",
    "mcapval": "20.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531521,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE971E01016",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.2 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/desh-rakshak-351394-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-intense-selling-pressure-amid-lower-circuit-lockdown-3748718",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DeshRakshakAush_only_sellers_3748718.png",
        "date": "2025-12-05 10:25:32",
        "description": "Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, with the stock registering a lower circuit and an absence of buyers. This development comes amid a series of consecutive losses over recent months, signalling distress selling and heightened market caution."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3746838",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/DeshRakshakAush_only_sellers_3746838.png",
        "date": "2025-12-04 13:41:33",
        "description": "Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.86% today and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market benchmarks."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Sees Unprecedented Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-hits-upper-circuit-amidst-unprecedented-buying-interest-3735827",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_buyers_3735827.png",
        "date": "2025-11-28 15:15:49",
        "description": "Desh Rakshak Aushdhalaya Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand amid a backdrop of mixed performance metrics over various time frames."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3731118",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3731118.png",
        "date": "2025-11-26 10:10:31",
        "description": "Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing severe selling pressure with no buyers in the queue, signalling distress selling and a notable shift in market sentiment. The stock has recorded consecutive declines over the past four days, reflecting a challenging phase for investors amid a broader market context."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Sees Extraordinary Buying Interest Amid Upper Circuit Scenario",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-unprecedented-buying-interest-amidst-price-decline-3730812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_buyers_3730812.png",
        "date": "2025-11-26 09:50:35",
        "description": "Desh Rakshak Aushdhalaya Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-amid-lower-circuit-lockdown-3728104",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3728104.png",
        "date": "2025-11-25 09:40:40",
        "description": "Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, registering a sharp decline over the past week with no buyers visible in the order book. The stock’s performance contrasts starkly with broader market trends, signalling distress selling and heightened investor caution."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3725368",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3725368.png",
        "date": "2025-11-24 11:30:32",
        "description": "Desh Rakshak Aushdhalaya Ltd experienced a pronounced decline in trading activity today, marked by exclusive selling interest and a sharp drop in its share price. The stock opened sharply lower and remained at its intraday low throughout the session, signalling distress selling and a lack of buyer support in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Is Desh Rakshak overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-desh-rakshak-overvalued-or-undervalued-3723547",
        "imagepath": "",
        "date": "2025-11-24 08:09:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Understanding Desh Rakshak’s Current Valuation Metrics</strong></p>\n<p>As of 21 Nov 2025, Desh Rakshak’s valuation grade was revised to fair, reflecting a more balanced assessment compared to its previous expensive rating. The company’s price-to-earnings (PE) ratio stands at 37.17, which is relatively high but not uncommon in the pharmaceutical industry, where growth prospects often justify premium multiples. The price-to-book (P/B) ratio of 1.90 suggests the stock is trading at nearly twice its book value, indicating moderate investor confidence in its asset base and future earnings potential.</p>\n<p>Enterprise value multiples further support this fair valuation stance. The EV to EBIT ratio is 23.04, while EV to EBITDA is 14.92, both figures signalling a valuation that is elevated but not e..."
      },
      {
        "title": "Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Sharp Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/desh-rakshak-aushdhalaya-faces-severe-selling-pressure-hits-lower-circuit-amid-market-turmoil-3720170",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/DeshRakshakAush_only_sellers_3720170.png",
        "date": "2025-11-21 09:50:25",
        "description": "Desh Rakshak Aushdhalaya Ltd experienced a pronounced downturn on 21 Nov 2025, marked by exclusive selling activity and a significant drop in its share price. The stock’s performance today starkly contrasts with broader market trends, signalling distress selling and heightened investor caution within the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 189,
    "sid": "351394",
    "stock_news_url": "https://www.marketsmojo.com/news/desh-rakshak-aushdhalaya-351394"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Pre Intimation Of The Board Meeting As Per Regulation 29 Of The SEBI (LODR) Reg 2015 And Closure Of Trading Window",
      "datetime": "02-Dec-2025",
      "details": "Desh Rakshak Aushdhalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/12/2025 inter alia to consider and approve 1)To grant leave of Absence if any ascertain Quorum and take roll call if required 2)To take note the minutes 3)To consider and approve postpone decision for raising of funds by create offer issue and allot warrants convertible into equity shares through preferential issue 4)To consider and approve Audited Financial Statements 5)To consider and approve re-appointment of Mr. Tosh Kumar Jain liable to retire by rotatio. 6)To consider and approve regularisation of Mr. Rajesh Kumar Gupta 7)To consider and approve regularisation of Mrs. Cheena Golani 8)To consider and recommend the appointment of Mr. Ramesh Chandra Sharma as Secretarial Auditor 9)To consider and approve increase in limit of payment of managerial remuneration and detailed agenda mention in the attached intimation.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Preferential Issue",
      "datetime": "27-Nov-2025",
      "details": "The company submit intimation regarding raising of funds by create offer issue and allot warrants convertible into equity shares under Regulation 30 of the SEBI (LODR) Reg 2015",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 27Th Day Of November 2025 Meeting Commenced At 03:00 P.M. And Concluded At 04:00 P.M. Pursuant To Para A Of Part A Of Schedule III And Reg 30 Of The SEBI (LODR) Reg 2015",
      "datetime": "27-Nov-2025",
      "details": "With reference to the captioned subject the company hereby inform that the Board of Directors of the Company in its meeting held on Thursday 27th day of November 2025 has discussed considered and took noted and approved the following matters as per the notice and agenda of the Board Meeting: 1) Took noted Closure of Trading window. 2) Considered and Approved proposal for raising of funds by create offer issue and allot warrants convertible into equity shares through private offerings / preferential issue in accordance with the Cos Act 2013 the SEBI (ICDR) Regulations and all other applicable laws as may be considered appropriate in such manner as may be determined by the Board of Directors subject to approval of the shareholders of the Company and receipt of other regulatory/statutory approvals as may be required. 3)Considered and Approved appointment of Registered Valuer Mr. Arpit Baslas.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "06 Dec 2025"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses

2025-12-05 10:25:32

Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing significant selling pressure, with the stock registering a lower circuit and an absence of buyers. This development comes amid a series of consecutive losses over recent months, signalling distress selling and heightened market caution.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amidst Consecutive Losses

2025-12-04 13:41:33

Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.86% today and exhibiting a complete absence of buyers. This extreme selling activity signals distress among investors, as the stock continues to underperform both its sector and the broader market benchmarks.

Desh Rakshak Aushdhalaya Sees Unprecedented Buying Interest Amid Upper Circuit Scenario

2025-11-28 15:15:49

Desh Rakshak Aushdhalaya Ltd has attracted extraordinary buying interest, with the stock hitting the upper circuit and registering only buy orders in the queue. This rare market phenomenon signals a potential multi-day circuit scenario, reflecting intense demand amid a backdrop of mixed performance metrics over various time frames.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-26 10:10:31

Desh Rakshak Aushdhalaya Ltd, a key player in the Pharmaceuticals & Biotechnology sector, is currently experiencing severe selling pressure with no buyers in the queue, signalling distress selling and a notable shift in market sentiment. The stock has recorded consecutive declines over the past four days, reflecting a challenging phase for investors amid a broader market context.

Desh Rakshak Aushdhalaya Sees Extraordinary Buying Interest Amid Upper Circuit Scenario

2025-11-26 09:50:35

Desh Rakshak Aushdhalaya Ltd has attracted remarkable buying interest, with the stock hitting an upper circuit and registering only buy orders in the queue. This unusual market activity signals a potential multi-day circuit scenario, reflecting strong demand despite recent price volatility.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-25 09:40:40

Desh Rakshak Aushdhalaya Ltd has encountered significant selling pressure, registering a sharp decline over the past week with no buyers visible in the order book. The stock’s performance contrasts starkly with broader market trends, signalling distress selling and heightened investor caution.

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Consecutive Losses

2025-11-24 11:30:32

Desh Rakshak Aushdhalaya Ltd experienced a pronounced decline in trading activity today, marked by exclusive selling interest and a sharp drop in its share price. The stock opened sharply lower and remained at its intraday low throughout the session, signalling distress selling and a lack of buyer support in the Pharmaceuticals & Biotechnology sector.

Is Desh Rakshak overvalued or undervalued?

2025-11-24 08:09:52

Understanding Desh Rakshak’s Current Valuation Metrics

As of 21 Nov 2025, Desh Rakshak’s valuation grade was revised to fair, reflecting a more balanced assessment compared to its previous expensive rating. The company’s price-to-earnings (PE) ratio stands at 37.17, which is relatively high but not uncommon in the pharmaceutical industry, where growth prospects often justify premium multiples. The price-to-book (P/B) ratio of 1.90 suggests the stock is trading at nearly twice its book value, indicating moderate investor confidence in its asset base and future earnings potential.

Enterprise value multiples further support this fair valuation stance. The EV to EBIT ratio is 23.04, while EV to EBITDA is 14.92, both figures signalling a valuation that is elevated but not e...

Desh Rakshak Aushdhalaya Faces Intense Selling Pressure Amid Sharp Decline

2025-11-21 09:50:25

Desh Rakshak Aushdhalaya Ltd experienced a pronounced downturn on 21 Nov 2025, marked by exclusive selling activity and a significant drop in its share price. The stock’s performance today starkly contrasts with broader market trends, signalling distress selling and heightened investor caution within the Pharmaceuticals & Biotechnology sector.

View All News

Announcement

Board Meeting Intimation for Pre Intimation Of The Board Meeting As Per Regulation 29 Of The SEBI (LODR) Reg 2015 And Closure Of Trading Window

02-Dec-2025 | Source : BSE

Desh Rakshak Aushdhalaya Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/12/2025 inter alia to consider and approve 1)To grant leave of Absence if any ascertain Quorum and take roll call if required 2)To take note the minutes 3)To consider and approve postpone decision for raising of funds by create offer issue and allot warrants convertible into equity shares through preferential issue 4)To consider and approve Audited Financial Statements 5)To consider and approve re-appointment of Mr. Tosh Kumar Jain liable to retire by rotatio. 6)To consider and approve regularisation of Mr. Rajesh Kumar Gupta 7)To consider and approve regularisation of Mrs. Cheena Golani 8)To consider and recommend the appointment of Mr. Ramesh Chandra Sharma as Secretarial Auditor 9)To consider and approve increase in limit of payment of managerial remuneration and detailed agenda mention in the attached intimation.

Announcement under Regulation 30 (LODR)-Preferential Issue

27-Nov-2025 | Source : BSE

The company submit intimation regarding raising of funds by create offer issue and allot warrants convertible into equity shares under Regulation 30 of the SEBI (LODR) Reg 2015

Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday 27Th Day Of November 2025 Meeting Commenced At 03:00 P.M. And Concluded At 04:00 P.M. Pursuant To Para A Of Part A Of Schedule III And Reg 30 Of The SEBI (LODR) Reg 2015

27-Nov-2025 | Source : BSE

With reference to the captioned subject the company hereby inform that the Board of Directors of the Company in its meeting held on Thursday 27th day of November 2025 has discussed considered and took noted and approved the following matters as per the notice and agenda of the Board Meeting: 1) Took noted Closure of Trading window. 2) Considered and Approved proposal for raising of funds by create offer issue and allot warrants convertible into equity shares through private offerings / preferential issue in accordance with the Cos Act 2013 the SEBI (ICDR) Regulations and all other applicable laws as may be considered appropriate in such manner as may be determined by the Board of Directors subject to approval of the shareholders of the Company and receipt of other regulatory/statutory approvals as may be required. 3)Considered and Approved appointment of Registered Valuer Mr. Arpit Baslas.

Corporate Actions

BOARD MEETING

06 Dec 2025

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available